| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Cost of Revenue | – | – | – | – |
| Gross Profit | – | – | – | – |
| Operating Expenses | $123.17M | $62.30M | $26.06M | $19.43M |
| R&D | $94.48M | $38.31M | $16.46M | $15.47M |
| SG&A | $28.68M | $23.98M | $9.60M | $3.96M |
| Operating Income | -$123.17M | -$62.30M | -$26.06M | -$19.43M |
| Interest Expense | – | – | $4.95M | $1.42M |
| Tax Expense | $0.00 | -$19.00K | $17.00K | $22.00K |
| Net Income | -$117.30M | -$55.14M | -$99.92M | -$24.46M |
| EPS (basic) | 2.2900 | 1.4600 | 151.2200 | 44.3000 |
| EPS (diluted) | 2.2900 | 1.4600 | 151.2200 | 44.3000 |
| Shares (diluted) | $51.12M | $37.78M | $692.61K | $655.15K |